Literature DB >> 9825788

Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy.

P Bonanni1, R Colombai, G Franchi, A Lo Nostro, N Comodo, E Tiscione.   

Abstract

An outbreak of hepatitis A started in late October 1996 in a nursery school in Tuscany, Italy. A programme of hepatitis A vaccination without the use of immunoglobulin started at the beginning of December 1996 and included 33 children, 21 household contacts and 6 adults working in the school. Overall, 11 cases occurred in children attending the school (attack rate 27%) and 10 among their household contacts (attack rate 9 %). The latter also included parents, and, in two cases, grandmothers. The data indicate that susceptibility to HAV has increased over recent decades in central Italy. Past and recent experience shows that the usual duration of hepatitis A epidemics in the absence of immune prophylaxis is longer than that described here. The use of hepatitis A vaccine probably contributed to the early extinction of the outbreak, because no further cases were notified in the area after 7 February 1997.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9825788      PMCID: PMC2809534          DOI: 10.1017/s0950268898001411

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  3 in total

1.  The effect of policy changes on hepatitis A vaccine uptake in Arizona children, 1995-2008.

Authors:  Kacey C Ernst; Kristen Pogreba-Brown; Lisa Rasmussen; Laura M Erhart
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

2.  A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix™ in healthy adults.

Authors:  Olivier Van Der Meeren; Priya Crasta; Marc de Ridder
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Vaccination against hepatitis A in children: A review of the evidence.

Authors:  Paolo Bonanni; Sara Boccalini; Angela Bechini
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.